NCT07425405 Daily Screen Exposure and Preoperative Anxiety in Children Aged 2-5 Years
| NCT ID | NCT07425405 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kanuni Sultan Suleyman Training and Research Hospital |
| Condition | Preoperative Anxiety |
| Study Type | OBSERVATIONAL |
| Enrollment | 275 participants |
| Start Date | 2026-03-11 |
| Primary Completion | 2027-01-23 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 275 participants in total. It began in 2026-03-11 with a primary completion date of 2027-01-23.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective observational study aims to evaluate whether daily screen exposure duration is associated with preoperative anxiety levels in children aged 2-5 years undergoing elective surgery. Screen exposure in early childhood has been associated with emotional and behavioral outcomes, including increased anxiety. However, its potential impact on anxiety in acute stress situations such as surgery has not been previously investigated. Preoperative anxiety in children is associated with difficult anesthetic induction, increased postoperative agitation, prolonged recovery, and behavioral disturbances. In this study, parents will complete a structured questionnaire assessing their child's daily screen exposure duration and related factors. Children will be categorized into three groups according to reported daily screen time: less than 1 hour per day, 1-2 hours per day, and more than 2 hours per day. Preoperative anxiety will be assessed immediately before anesthesia induction using the Modified Yale Preoperative Anxiety Scale (mYPAS), a validated observational tool for measuring anxiety in young children. No additional medical interventions will be performed beyond routine clinical care. The study seeks to determine whether higher screen exposure is associated with increased preoperative anxiety levels and to identify potential risk factors contributing to anxiety in preschool children undergoing surgery.
Eligibility Criteria
Inclusion Criteria: * Children aged 2 to 5 years * Scheduled for elective surgical procedures under general anesthesia * American Society of Anesthesiologists (ASA) physical status I-III * Parent or legal guardian able to provide written informed consent * Parent able to complete the structured questionnaire in Turkish Exclusion Criteria: * Premedication administered or planned prior to anxiety assessment * Emergency surgical procedures * Known developmental delay or neurodevelopmental disorder * Known psychiatric disorder * Visual or hearing impairment that may interfere with behavioral assessment * Chronic use of sedative, antipsychotic, or antiepileptic medications * Anticipated need for postoperative intensive care * Incomplete or unreliable questionnaire data * Inability to perform mYPAS assessment prior to anesthesia induction
Frequently Asked Questions
Who can join the NCT07425405 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 5 Years, studying Preoperative Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07425405 currently recruiting?
Yes, NCT07425405 is actively recruiting participants. Visit ClinicalTrials.gov or contact Kanuni Sultan Suleyman Training and Research Hospital to inquire about joining.
Where is the NCT07425405 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07425405 clinical trial?
NCT07425405 is sponsored by Kanuni Sultan Suleyman Training and Research Hospital. The trial plans to enroll 275 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.